Talk to Jay about these topics and more:

• Understanding cardiac safety requirements, including protocol design 
• Sponsor support at FDA meetings 
• Early phase development 
• Working with data and safety monitoring boards 
• Cardiac arrhythmias and electrophysiology  

Talk to Cassie about these topics and more:

• Navigating U.S. regulatory requirements, IND Submission, and Phase 1 startup and conduct 
• Efficiencies and guidance in running Phase 1 of clinical development  
• Understanding cardiac safety requirements and the best cost-saving methods 
• Developing new service programs as needs emerge 
• Rapid operational scaling/growth, strategic planning, and recapitalization